Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Goodyear Tire & Rubber Co (GT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Goodyear Tire & Rubber Co — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.03 (market cap $3.94B), while Goodyear Tire & Rubber Co trades at $4.39 (market cap $1.31B). The key difference: Edgewise Therapeutics Inc. Common Stock is far larger — about 3× Goodyear Tire & Rubber Co's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Goodyear Tire & Rubber Co nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Goodyear Tire & Rubber Co for 58 Days on average.
| EWTX | GT | |
|---|---|---|
Market Cap | $3.94B | $1.31B |
Volume | 810,104 | 8,331,802 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.35 | $10.54 |
52-Week Low | $14.89 | $4.38 |
Typical Hold Time | 0 Days | 58 Days |
Enterprise Value | $3.48B | $8.66B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
The Goodyear Tire & Rubber Company (GT) trades at $4.38, down 2.45% on the day, reflecting persistent bearish technical momentum. The stock shows deeply discounted valuation ratios, including a P/E of 4.69 and P/B of 0.46, but faces significant fundamental challenges with a net income margin of -14.37% and negative ROE of -63.93% for 2025. Recent earnings have been mixed, with Q2 2026 beating expectations but still posting a loss. Cash flow trends show modest improvement, with net cash flow turning positive in 2025 and 2026. Analyst sentiment is mixed, with a consensus price target of $8.00 implying substantial upside, though technical indicators remain bearish overall.
Outlook: GT presents a high-risk, high-reward opportunity. The stock is fundamentally undervalued, and successful execution of its restructuring and margin expansion strategy could drive significant appreciation toward the analyst target. However, persistent losses, high debt, and competitive pressures pose substantial risks. Investors should weigh the potential for a turnaround against the company's current financial instability and bearish market sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Goodyear Tire & Rubber Co
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →
